Company Profile
Coya Therapeutics Stock Price, News & Catalysts
- Ticker:
- COYA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
4.96 USD (+1.85%)
Close
Last updated: August 24, 2026
111M USD
Market cap
Why the stock is moving
As of Aug 24, 2026, COYA closed up 1.85% at $4.96. No new same-company headline was identified in the current news window.
Company overview
Business overview
Coya Therapeutics is a biotechnology company focused on immunomodulation and neurodegenerative disease, especially ALS and related conditions. Its story centers on modulating immune pathways to potentially slow neurodegeneration.
Geographic Base and Sector Classification
Coya is headquartered in the United States and listed on NASDAQ. It sits in neuroscience and immunology biotechnology.
Business Model Characteristics
The company depends on clinical data, translational validation, and capital support while developing a narrow pipeline. Investors watch early efficacy signals and whether the biology can support a differentiated CNS thesis.
Position Within the Biotechnology Landscape
Coya occupies a specialized immunology-neuroscience niche within biotech. The stock is catalyst-sensitive because it is still proving whether the platform can matter in neurodegeneration.
Future catalysts
- Coya’s catalysts are its immunomodulation and neuroinflammation programs, where the next clinical update can change how investors view the company. The company remains early and data-dependent.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Coya Therapeutics (COYA)?
Coya Therapeutics (COYA) most recently closed at 4.96 USD, a +1.85% move versus the previous session.
What is the market cap of Coya Therapeutics (COYA)?
Coya Therapeutics currently has a market capitalization of 111M USD on BioPharmSignal.
What does Coya Therapeutics do?
Coya Therapeutics is a biotechnology company focused on immunomodulation and neurodegenerative disease, especially ALS and related conditions. Its story centers on modulating immune pathways to potentially slow neurodegeneration.
On which exchange is COYA stock listed?
Coya Therapeutics (COYA) is associated with NASDAQ, United States, Biopharma.
What is Coya?
Coya’s catalysts are its immunomodulation and neuroinflammation programs, where the next clinical update can change how investors view the company.
Which conditions is Coya Therapeutics targeting with Coya?
Coya Therapeutics is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does Coya Therapeutics describe recent progress with Coya?
Coya’s catalysts are its immunomodulation and neuroinflammation programs, where the next clinical update can change how investors view the company.
What is Therapeutics?
Coya Therapeutics is a biotechnology company focused on immunomodulation and neurodegenerative disease, especially ALS and related conditions.